Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

BACKGROUND: HVTN 505 was a human immunodeficiency virus type 1 (HIV-1) preventive vaccine efficacy trial of a DNA/recombinant adenovirus serotype 5 (rAd5) vaccine regimen. We assessed antibody responses measured 1 month after final vaccination (month 7) as correlates of HIV-1 acquisition risk. METHO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Fong, Youyi, Shen, Xiaoying, Ashley, Vicki C, Deal, Aaron, Seaton, Kelly E, Yu, Chenchen, Grant, Shannon P, Ferrari, Guido, deCamp, Allan C, Bailer, Robert T, Koup, Richard A, Montefiori, David, Haynes, Barton F, Sarzotti-Kelsoe, Marcella, Graham, Barney S, Carpp, Lindsay N, Hammer, Scott M, Sobieszczyk, Magda, Karuna, Shelly, Swann, Edith, DeJesus, Edwin, Mulligan, Mark, Frank, Ian, Buchbinder, Susan, Novak, Richard M, McElrath, M Juliana, Kalams, Spyros, Keefer, Michael, Frahm, Nicole A, Janes, Holly E, Gilbert, Peter B, Tomaras, Georgia D
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018910/
https://ncbi.nlm.nih.gov/pubmed/29325070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars